Toll-like receptor 9 1635A/G polymorphism is associated with HIV-1 rebound after four weeks of interruption of antiretroviral therapy.

Authors

Alejandro Vallejo
Sonia Molina-Pinelo
Beatriz De Felipe
María Abad-Fernández
María Francisca González-Escribano
Manuel Leal
Natalia Soriano-Sarabia, George Washington University

Document Type

Journal Article

Publication Date

7-8-2020

Journal

Journal of Acquired Immune Deficiency Syndromes

DOI

10.1097/QAI.0000000000002437

Comments

Online ahead of print

APA Citation

Vallejo, A., Molina-Pinelo, S., De Felipe, B., Abad-Fernández, M., González-Escribano, M., Leal, M., & Soriano-Sarabia, N. (2020). Toll-like receptor 9 1635A/G polymorphism is associated with HIV-1 rebound after four weeks of interruption of antiretroviral therapy.. Journal of Acquired Immune Deficiency Syndromes, (). http://dx.doi.org/10.1097/QAI.0000000000002437

Peer Reviewed

1